NCT06406465 2026-03-18A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and ToxicityNational Institutes of Health Clinical Center (CC)Phase 2 Recruiting60 enrolled
NCT06561048 2026-03-16Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaCorvus Pharmaceuticals, Inc.Phase 3 Recruiting150 enrolled